A Phase 2b/3 Multi-center, radomized, double-blind, multi-dose, placebo-controlled, parallel-group set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis